HD-OPM Archive
Topics › Low-carb, keto & carnivore

Keto beat Mediterranean and low-fat diets on liver fat and glycemia at equal weight loss

Gokhan Can · Aug 27, 2026 · ♥ 6 reactions · 8 comments · original Facebook post
Low-carb, keto & carnivoreWeight, visceral & liver fatInsulin resistance & diabetes
AI summary & key facts

Petersen et al. (Cell Metabolism, 2026) fed 42 adults with obesity, prediabetes and fatty liver all meals in a controlled trial until ~10% weight loss. All diets improved muscle insulin sensitivity and body composition, but the very-low-carb ketogenic diet gave clearly larger improvements in liver metabolic function, intrahepatic fat and glycemic control.

Comparative Efficacy of Dietary Macronutrients on Liver Insulin Resistance During Matched Weight Loss

Aug, 2026

The study, "Effect of diet macronutrient content on the cardiometabolic response to weight loss: A randomized clinical trial" by Petersen et al., investigates how three popular diets with vastly different macronutrient profiles influence metabolic health in individuals with metabolically unhealthy obesity. The core finding is that while a moderate 10% weight loss provides universal benefits for skeletal muscle insulin sensitivity and body composition regardless of the diet, a very-low-carbohydrate ketogenic diet delivered vastly superior improvements in liver metabolic function, intrahepatic fat reduction, and glycemic control compared to Mediterranean and very-low-fat plant-forward diets.

Background and Study Objectives

Obesity is a primary driver of prediabetes, insulin resistance, and metabolic dysfunction-associated steatotic liver disease (MASLD). The standard clinical treatment for these conditions is weight loss achieved through a caloric deficit. However, a major outstanding question in clinical nutrition is whether the specific macronutrient composition of a diet (the ratio of carbohydrates, fats, and proteins) provides unique metabolic benefits independent of the weight loss itself.

Previous randomized trials have struggled to answer this question definitively because participants often achieve unequal amounts of weight loss or fail to strictly adhere to their assigned diets. To eliminate these confounding variables, the researchers conducted a highly controlled feeding trial where all meals were prepared and provided to the participants. The objective was to observe the cardiometabolic effects of a strictly matched ~10% weight loss across three distinct dietary protocols.

Study Design and Methodology

The trial enrolled participants with metabolically unhealthy obesity, defined as having a Body Mass Index (BMI) between 30.0 and 50.0 kg/m2, prediabetes, and hepatic steatosis (liver fat content ≥5%). Out of 55 initial participants, 42 completed the trial (14 per diet group). The participants had an average age of 43.2 years and an average initial BMI of 38.9 kg/m2.

Participants were randomized into three dietary interventions. To ensure absolute adherence, a metabolic kitchen provided all packed-out meals and snacks, and participants were required to log all food consumption (which showed >95% adherence).

The macronutrient breakdowns for the three diets were:

Participants were kept on a calorie-restricted track until they achieved a 10% weight loss, which took an average of 4.6 to 5.4 months. Once the weight loss target was hit, calories were adjusted to stabilize their weight for 3 to 4 weeks before follow-up metabolic testing was conducted to ensure active weight loss did not skew the results.

Key Numerical Findings and Results

Weight Loss and Body Composition

The researchers successfully achieved uniform weight loss across all cohorts, completely isolating the variable of macronutrient composition.

Insulin Sensitivity (Muscle vs. Liver)

The researchers utilized a highly rigorous hyperinsulinemic-euglycemic clamp procedure combined with isotope tracers to measure insulin sensitivity in specific organs.

Liver Fat and Hepatic Function

Hepatic steatosis is a major risk factor for cardiovascular disease and liver failure. All groups saw reductions in intrahepatic triglyceride (liver fat) content, but the magnitude varied significantly by diet:

Furthermore, hepatic de novo lipogenesis (the process by which the liver synthesizes new fat from excess carbohydrates) decreased heavily in the ketogenic and Mediterranean groups, but remained unchanged in the very-low-fat plant-forward group. The drop was most profound in the ketogenic cohort.
Glycemic Control, Hormones, and Prediabetes Remission

The trial utilized 24-hour serial blood sampling to track hormone and substrate profiles throughout the day, providing a comprehensive view of metabolic function beyond standard fasting tests.

Blood Lipids and Cardiovascular Markers

A common concern regarding ketogenic diets is their high saturated fat content and potential to negatively impact cholesterol and cardiovascular health. This study provided evidence to the contrary in the context of weight loss:

Mechanistic Insights

The researchers suggest that the profound improvements in liver health seen in the ketogenic group are driven by the shifting ratios of circulating hormones—specifically, the massive drop in insulin coupled with a sharp rise in glucagon.

Because carbohydrates were restricted to just 4% of daily energy, the ketogenic participants had vastly lower circulating glucose. This lack of glucose reduced the pancreas's need to secrete insulin. Simultaneously, glucagon levels rose to ensure the body maintained baseline energy. This specific high-glucagon, low-insulin environment biologically forces the liver to halt de novo lipogenesis (fat creation) and accelerates the breakdown and oxidation of existing intrahepatic triglycerides (fat burning).

Additionally, the trial showed that sustaining a basal level of nonesterified fatty acids (NEFAs) throughout the day—which happened only in the ketogenic group due to continuous fat burning—did not worsen skeletal muscle insulin resistance, upending some previous metabolic hypotheses.

Safety and Biomarkers

No serious adverse events occurred during the trial, and no participants withdrew due to dietary complications. The ketogenic group actually demonstrated an improvement in estimated glomerular filtration rate (eGFR), an indicator of kidney function, largely due to a drop in cystatin C. Furthermore, urinary 8-isoprostane—a key biomarker for lipid peroxidation and systemic oxidative stress—decreased significantly only in the ketogenic group.

Study Limitations

The authors noted a few key limitations. First, the sample size was relatively small (42 completed participants), meaning minor secondary statistical differences between the diets might have been missed. Second, because all food was carefully prepared and provided, the results demonstrate physiological efficacy rather than real-world effectiveness; achieving this level of strict carbohydrate restriction is notoriously difficult for patients in free-living environments. Finally, the study evaluated the diets during active weight loss and a brief stabilization phase, so it cannot determine if these specific metabolic advantages persist long-term if the diet is used purely for weight maintenance.

Conclusion

The clinical trial showed that dietary macronutrient composition significantly alters the cardiometabolic benefits of weight loss. While losing 10% of body weight is universally beneficial for skeletal muscle sensitivity and fat reduction, implementing a very-low-carbohydrate ketogenic diet supercharged hepatic recovery. By profoundly lowering 24-hour insulin and raising glucagon, the ketogenic diet drove superior reductions in liver fat, reversed prediabetes at higher rates, and improved overall cardiovascular risk markers better than calorie-matched Mediterranean or low-fat diets in populations with metabolically unhealthy obesity.

Paper · Cell Metabolism · 2026Effect of diet macronutrient content on the cardiometabolic response to weight loss: A randomized clinical trialcell.com

Research cited

#weightloss#liver#insulin#mediterranean#carbohydrate#liverfat#muscle#prediabetes
← newer: Video accuses Diary of a CEO of knowingly spreading health molder: Post defends COVID-19 vaccine effectiveness against politica →